Tranylcypromine Sulfate
NDC Package 47781-517-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Tranylcypromine Sulfate is tranylcypromine is an antidepressant (monoamine oxidase inhibitor). Marketed by Alvogen Inc., this product is identified by NDC 47781-517 and is authorized under FDA application ANDA206856.

Identification & Billing

NDC Package Code
47781-517-01
Package Description
100 TABLET, FILM COATED in 1 BOTTLE
Product Code
47781-517
11-Digit Billing Format
47781051701
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Tranylcypromine Sulfate
Dosage Form
-
Usage Information
Tranylcypromine is an antidepressant (monoamine oxidase inhibitor). This medication treats depression by restoring the balance of certain natural substances (neurotransmitters) in the brain. Tranylcypromine can improve your mood and feelings of well-being. Usually, this medication is used in persons who have not responded to treatment with other drugs.

Regulatory & Marketing

Labeler Name
Alvogen Inc.
FDA Application #
ANDA206856
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-17-2018
End Marketing Date
08-01-2021
Listing Expiration
08-01-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 47781-517-01 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Tranylcypromine Sulfate, labeled by Alvogen Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Alvogen Inc. on April 17, 2018. The current certification is valid through August 01, 2021.

What are the primary indications for this medication?

Tranylcypromine is an antidepressant (monoamine oxidase inhibitor). This medication treats depression by restoring the balance of certain natural substances (neurotransmitters) in the brain. Tranylcypromine can improve your mood and feelings of well-being. Usually, this medication is used in persons who have not responded to treatment with other drugs.

How is this Alvogen Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 47781051701. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
47781-517-01
11-Digit CMS (5-4-2)
47781-0517-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.